Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer

por Furman, Craig, Puyang, Xiaoling, Zhang, Zhaojie, Wu, Zhenhua J., Banka, Deepti, Aithal, Kiran B., Albacker, Lee A., Hao, Ming-Hong, Irwin, Sean, Kim, Amy, Montesion, Meagan, Moriarty, Alyssa D., Murugesan, Karthikeyan, Nguyen, Tuong-Vi, Rimkunas, Victoria, Sahmoud, Tarek, Wick, Michael J., Yao, Shihua, Zhang, Xun, Zeng, Hao, Vaillancourt, Frédéric H., Bolduc, David M., Larsen, Nicholas, Zheng, Guo Zhu, Prajapati, Sudeep, Zhu, Ping, Korpal, Manav
Publicado 2022